Press Release
Home > Press Release > PR Newswire
China Bio-Immunity Corporation to Report Third Quarter 2008 Financial Results
Font Scale: 
DALIAN, China, Nov. 12 /Xinhua-PRNewswire-FirstCall/ -- China Bio-ImmunityCorporation (OTC Bulletin Board: "CHHB") (China Bio-Immunity" or "theCompany"), today announced that it plans to release third quarter 2008financial results on November 14, 2008, and will hold a conference call todiscuss the results on November 17, 2008, the following business day.
Details of the call:
The Company will hold a conference call at 9:00 AM ET on November 17, 2008to discuss its fiscal third quarter 2008 results. Listeners may access thecall by dialing 1-888-264-8952 or 1-913-312-1492 for international callers,access code: 9830874. A webcast will also be available through the Companywebsite at http://www.jgad-bio.com . A replay of the call will be availablethrough December 1, 2008. Listeners may access the replay by dialing 1-888-203-1112 or 1-719-457-0820 for international callers, access code: 9830874.
About China Bio-Immunity
Based in Dalian, China, China Bio-Immunity develops, produces,manufactures and markets internally developed vaccine-based prophylactics andtherapeutics. The Company has sales and marketing efforts in the 24 mainprovinces and major cities in the People's Republic of China ("P.R.C."). Itsprincipal products, its Rabies Vaccine and Mumps Vaccine, are sold anddistributed by a network of wholesale distributors, as well as through retailcustomers. In addition to the current distribution structure, the Companyplans to further market its products through distribution agreements withlocal agents in several developing countries, including, but not limited toIndia, South Africa, and countries throughout Southeast Asia. To learn moreabout the Company, visit http://www.jgad-bio.com .
SOURCE China Bio-Immunity Corporation
The Company will hold a conference call at 9:00 AM ET on November 17, 2008to discuss its fiscal third quarter 2008 results. Listeners may access thecall by dialing 1-888-264-8952 or 1-913-312-1492 for international callers,access code: 9830874. A webcast will also be available through the Companywebsite at http://www.jgad-bio.com . A replay of the call will be availablethrough December 1, 2008. Listeners may access the replay by dialing 1-888-203-1112 or 1-719-457-0820 for international callers, access code: 9830874.
About China Bio-Immunity
Based in Dalian, China, China Bio-Immunity develops, produces,manufactures and markets internally developed vaccine-based prophylactics andtherapeutics. The Company has sales and marketing efforts in the 24 mainprovinces and major cities in the People's Republic of China ("P.R.C."). Itsprincipal products, its Rabies Vaccine and Mumps Vaccine, are sold anddistributed by a network of wholesale distributors, as well as through retailcustomers. In addition to the current distribution structure, the Companyplans to further market its products through distribution agreements withlocal agents in several developing countries, including, but not limited toIndia, South Africa, and countries throughout Southeast Asia. To learn moreabout the Company, visit http://www.jgad-bio.com .
SOURCE China Bio-Immunity Corporation
For more iinformation, go to www.prnewswire.com
- Sponsored By
-
Recent Press Release
- 1 101domain Releases New Site, Services – Including Internationalized Domain Names (IDNs)
- 2 The Wave Of The Future! Electronic Walk-In Bill Payment Services, International Money Transfer, Prepaid Debit Cash Loading & Prepaid Cellular Phone Services For Merchant Retailers.
- 3 Pharmaceutical heads pull together to reverse the economic downturn
- 4 K7 Computing CEO Wins Best Member Award in AVAR 2008
- 5 WEST INDIES FULL SERVICE BANK NAMES EDCOMM BANKER’S ACADEMY TO DELIVER CUSTOM BANKER’S ACADEMY UNLIMITED TRAINING
- 6 RANDOLPH BANK RENEWS CONTRACT WITH EDCOMM BANKER’S ACADEMY FOR COMPLIANCE TRAINING
- 7 ABA APPROVES BANKER'S ACADEMY’S CONSUMER LENDING TRAINING FOR CONTINUING EDUCATION CREDITS FOR CPB CERTIFICATION
